California jury hits J&J with a multimillion dollar lawsuit
Category: #world  By Shikha Sinha  Date: 2018-05-27
  • share
  • Twitter
  • Facebook
  • LinkedIn

California jury hits J&J with a multimillion dollar lawsuit

A California jury has ordered a $25.7 million verdict againstJohnson & Johnson in a lawsuit filed by a woman who sued the company for not warning the consumer and being negligent about the possible health risksfrom its talc-based baby powder. Apparently, the woman – Joanne Anderson claims to have developed mesothelioma – a type of lung cancer linked with asbestos exposure, after having used Johnson & Johnson’s cancerbaby powder.

Sources reveal that the California jury originally handed down compensatory damages of USD 21.75 million to the victim after the trail. Later however, this amount was followed by another trail that led to the payment of an additional USD 4 million in punitive damages.

According to reports, Anderson, 66,revealed in the Los Angeles Superior Court that she used the baby powderon her hands and in her shoes for years.Apparently, she had also used the product when her children were younger, to help with diaper rash. As per some of the court experts, the victim in fact used the baby powder over 10,000 times.

Sources familiar with the matter further reveal that the doctors have diagnosed Anderson withpleural mesothelioma that is often caused because of exposure to asbestos. For the record, since 1970’s, talc used in all beauty and consumer products has been required to be free from asbestos.

A Johnson & Johnson spokeswomanmentioned in a company statement that the company is disappointed with the verdict from the panel and will soon begin the appeal process. She further added that the company will continue to defend the safety of the product as it does not cause mesothelioma or contain asbestos.

If reports are to be believed, similar allegations involving asbestos exposure have led to hundreds of cases against Johnson& Johnson. Additionally, there seem to be over thousands of discrete lawsuits in which women claimed that using the talcum powder for feminine hygieneled to them developing ovarian cancer.



About Author

Shikha Sinha

Email: [email protected]   

Shikha Sinha

Shikha currently manages content operations for a series of news and business portals including MSF, Algosonline, and the like. An electrical & electronics engineer by education, she has prior experience in content & technology writing, content marketing, market resea...

Read More

More News By Shikha Sinha

Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
Altimmune inks deal to acquire Spitfire Pharma and its NASH candidate
By Shikha Sinha

Altimmune, Inc., a clinical stage biopharma company, has recently confirmed the closing of a formerly announced acquisition of Spitfire Pharma, Inc., including the strong GLP-1/Glucagon receptor co-agonist product cand...

NeurologyLive expands SAP program by partnering with Cleveland Clinic
NeurologyLive expands SAP program by partnering with Cleveland Clinic
By Shikha Sinha

NeurologyLive has reportedly added the Cleveland Clinic to its Strategic Alliance Partnership (SAP) program. Michael J. Hennessy Jr., President of NeurologyLive’s parent company MJH Associates Inc., said in a sta...

Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
Neurocrine, Voyager reveal VY-AADC’s Phase I results at AAN 2019
By Shikha Sinha

Neurocrine Biosciences Inc., along with Voyager Therapeutics Inc., has reportedly announced the Phase 1 results from the VY-AADC trial in eight patients suffering from Parkinson’s disease. Apparently, the patient...